Dermatologists who administer chemotherapy and other drugs in their offices could see significant reductions in reimbursement levels as a result of an effort by the federal government to curtail Medicare's costs for drugs used to treat cancer.
Latex Gloves and the Americans With Disabilities Act
The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice
Managing Your Pediatric Dermatology Practice and Life: Insights from Brandie Metz, MD, and Megha Tollefson, MD
I Charged My Patient: I Was Sued
Residency Is Ending Soon: Key Financial Tips for Your Next Chapter
Career Insights: Advocating and Negotiating for PAs